155 related articles for article (PubMed ID: 36808311)
21. Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases.
Lwu S; Goetz P; Monsalves E; Aryaee M; Ebinu J; Laperriere N; Menard C; Chung C; Millar BA; Kulkarni AV; Bernstein M; Zadeh G
Oncol Rep; 2013 Feb; 29(2):407-12. PubMed ID: 23151681
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic resections for metastases: A twenty-year experience from a tertiary care center.
Di Franco G; Gianardi D; Palmeri M; Furbetta N; Guadagni S; Bianchini M; Bonari F; Sbrana A; Vasile E; Pollina LE; Mosca F; Di Candio G; Morelli L
Eur J Surg Oncol; 2020 May; 46(5):825-831. PubMed ID: 31806518
[TBL] [Abstract][Full Text] [Related]
23. Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer?
Shi AA; Digumarthy SR; Temel JS; Halpern EF; Kuester LB; Aquino SL
J Thorac Oncol; 2006 Mar; 1(3):205-10. PubMed ID: 17409858
[TBL] [Abstract][Full Text] [Related]
24. Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma.
Powell JW; Chung CT; Shah HR; Canute GW; Hodge CJ; Bassano DA; Liu L; Mitchell L; Hahn SS
J Neurosurg; 2008 Dec; 109 Suppl():122-8. PubMed ID: 19123898
[TBL] [Abstract][Full Text] [Related]
25. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery.
Chang EL; Selek U; Hassenbusch SJ; Maor MH; Allen PK; Mahajan A; Sawaya R; Woo SY
Neurosurgery; 2005 May; 56(5):936-45; discussion 936-45. PubMed ID: 15854241
[TBL] [Abstract][Full Text] [Related]
26. Renal Cell Carcinoma With Pulmonary Metastasis and Metachronous Non-Small Cell Lung Cancer.
Bowman IA; Pedrosa I; Kapur P; Brugarolas J
Clin Genitourin Cancer; 2017 Aug; 15(4):e675-e680. PubMed ID: 28258962
[TBL] [Abstract][Full Text] [Related]
27. Five-year survival and clinical correlates among patients with advanced non-small cell lung cancer, melanoma and renal cell carcinoma treated with immune check-point inhibitors in Australian tertiary oncology centres.
Brown LJ; da Silva IP; Moujaber T; Gao B; Hui R; Gurney H; Carlino M; Nagrial A
Cancer Med; 2023 Mar; 12(6):6788-6801. PubMed ID: 36404632
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials.
Gan CL; Stukalin I; Meyers DE; Dudani S; Grosjean HAI; Dolter S; Ewanchuk BW; Goutam S; Sander M; Wells C; Pabani A; Cheng T; Monzon J; Morris D; Basappa NS; Pal SK; Wood LA; Donskov F; Choueiri TK; Heng DYC
Eur J Cancer; 2021 Jul; 151():115-125. PubMed ID: 33975059
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor.
Mai KT; Landry DC; Robertson SJ; Commons AS; Burns BF; Thijssen A; Collins J
Pathol Res Pract; 2001; 197(10):671-5. PubMed ID: 11700888
[TBL] [Abstract][Full Text] [Related]
30. Metastatic renal cell carcinoma to pancreas and gastrointestinal tract: a clinicopathological study of 3 cases and review of literature.
Abdul-Ghafar J; Ud Din N; Saadaat R; Ahmad Z
BMC Urol; 2021 May; 21(1):84. PubMed ID: 34034720
[TBL] [Abstract][Full Text] [Related]
31. Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.
Goldberg SB; Gettinger SN; Mahajan A; Chiang AC; Herbst RS; Sznol M; Tsiouris AJ; Cohen J; Vortmeyer A; Jilaveanu L; Yu J; Hegde U; Speaker S; Madura M; Ralabate A; Rivera A; Rowen E; Gerrish H; Yao X; Chiang V; Kluger HM
Lancet Oncol; 2016 Jul; 17(7):976-983. PubMed ID: 27267608
[TBL] [Abstract][Full Text] [Related]
32. Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review.
Kierney PC; van Heerden JA; Segura JW; Weaver AL
Ann Surg Oncol; 1994 Jul; 1(4):345-52. PubMed ID: 7850534
[TBL] [Abstract][Full Text] [Related]
33. [Multimodal Treatment of Non-Small Cell Lung Cancer with Cerebral Metastases].
Kudelin N; Bölükbas S; Schirren J
Zentralbl Chir; 2015 Jun; 140(3):328-33. PubMed ID: 26114639
[TBL] [Abstract][Full Text] [Related]
34. Differential treatment responses to immune checkpoint inhibitor (ICI) therapy in a case of multiple primary malignancies: the programmed death ligand-1 (PD-L1) negative ureteral and lung metastasis from a clear cell renal cell carcinoma appearing after robotic-assisted partial nephrectomy progressed after ICI therapy, while synchronous PD-L1-positive primary lung squamous cell carcinoma responded very well to ICI therapy: a case report.
Urushibara M; Ishizaka K; Matsutani N; Takahashi M; Nagata M; Okumura T; Matsumoto Y; Tatsuoka S; Nenohi T; Amemiya T; Shimizu Y; Shirakawa T; Kato D
World J Surg Oncol; 2023 Feb; 21(1):37. PubMed ID: 36747242
[TBL] [Abstract][Full Text] [Related]
35. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.
Lagerwaard FJ; Levendag PC; Nowak PJ; Eijkenboom WM; Hanssens PE; Schmitz PI
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):795-803. PubMed ID: 10098435
[TBL] [Abstract][Full Text] [Related]
36. Metastasis to the thyroid gland: Characterization and survival of an institutional series spanning 28 years.
Stergianos S; Juhlin CC; Zedenius J; Calissendorff J; Falhammar H
Eur J Surg Oncol; 2021 Jun; 47(6):1364-1369. PubMed ID: 33642087
[TBL] [Abstract][Full Text] [Related]
37. Metastatic tumors to the nail unit: subungual metastases.
Cohen PR
Dermatol Surg; 2001 Mar; 27(3):280-93. PubMed ID: 11277898
[TBL] [Abstract][Full Text] [Related]
38. Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients.
Lehrer EJ; Ahluwalia MS; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Fakhoury KR; Rusthoven CG; Mathieu D; Trudel C; Malouff TD; Ruiz-Garcia H; Bonney P; Hwang L; Yu C; Zada G; Patel S; Deibert CP; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Jones BM; Green S; Sheehan JP; Trifiletti DM
J Neurosurg; 2023 May; 138(5):1178-1187. PubMed ID: 36115055
[TBL] [Abstract][Full Text] [Related]
39. Risk of intracranial hemorrhage and cerebrovascular accidents in non-small cell lung cancer brain metastasis patients.
Srivastava G; Rana V; Wallace S; Taylor S; Debnam M; Feng L; Suki D; Karp D; Stewart D; Oh Y
J Thorac Oncol; 2009 Mar; 4(3):333-7. PubMed ID: 19190519
[TBL] [Abstract][Full Text] [Related]
40. [Metastatic brain tumors].
Taddei GL; Moncini D; Raspollini MR; Mennonna P; Boddi V; Dini M; Buccoliero AM
Pathologica; 1999 Feb; 91(1):13-7. PubMed ID: 10396945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
